Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck.
第一作者:
Min,Yao
第一单位:
Department of Radiation Oncology, University Hospitals Case Medical Center, Seidman Cancer Hospital, Cleveland, Ohio.
作者:
主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 鳞状细胞(Carcinoma, Squamous Cell);无病生存(Disease-Free Survival);剂量效应关系, 药物(Dose-Response Relationship, Drug);用药计划表(Drug Administration Schedule);女(雌)性(Female);头颈部肿瘤(Head and Neck Neoplasms);人类(Humans);输注, 静脉内(Infusions, Intravenous);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);肿瘤侵润(Neoplasm Invasiveness);肿瘤分期(Neoplasm Staging);预后(Prognosis);放射治疗剂量(Radiotherapy Dosage);放射疗法, 辅助(Radiotherapy, Adjuvant);存活率(Survival Rate);紫杉烷类(Taxoids);治疗结果(Treatment Outcome)
DOI
10.1002/hed.23813
PMID
24954745
发布时间
2024-06-10
- 浏览2

Head & neck
1665-71页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文